2nd Jan 2013 16:37
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.
On 31 December 2012, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £13.43 per Ordinary Share, and notional ADSs at a price of $43.39 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 October 2012 to 31 December 2012:
Non Executive Director | Ordinary Shares | American Depositary Shares (ADSs) |
Sir Christopher Gent | 2,513.031 | |
Professor Sir Roy Anderson | 628.258 | |
Dr Stephanie Burns |
| 339.609 |
Stacey Cartwright | 349.032 | |
Sir Crispin Davis | 2,326.880 | |
Lynn Elsenhans | 611.296 | |
Judy Lewent | 169.804 | |
Sir Deryck Maughan | 679.218 | |
Dr Daniel Podolsky | 713.178 | |
Tom de Swaan | 860.946 | |
Jing Ulrich | 237.726 | |
Sir Robert Wilson | 628.258 | |
The Company and the Non-Executive Directors were informed of these allocations on 2 January 2013.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
2 January 2013
Related Shares:
Glaxosmithkline